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Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) are expected to play an
important role in heart therapies, in which hiPSC-CMs should generate sufﬁcient contractile force to
pump blood. However, recent studies have shown that the contractility of myocardial mimics composed
of hiPSC-CMs is lower than that of adult human myocardium. To examine the mechanism by which
contractile force output of hiPSC-CMs is weakened, we measured the contractile force of single hiPSC-
CMs and observed the ﬁbrous distribution of myosin II regulatory light chain (MRLC) of cardiac (con-
tributes to beating) and non-cardiac (does not contribute to beating) isoforms. Single hiPSC-CMs were
cultured on an extracellular matrix gel, and the contractile force and strain energy exerted on the gel
were measured. Strain energy was not uniform between cells and ranged from 0.2 to 5.8 pJ. The com-
bination of contractile force measurement and immunoﬂuorescent microscopy for MRLC isoforms
showed that cells with higher strain energy expressed the weakened non-cardiac myosin II ﬁbers
compared to those of cells with lower strain energy. Observation of cardiac and non-cardiac MRLC
showed that the MRLC isoforms formed heterogeneous ﬁlament networks. These results suggest that
strain energy output from single hiPSC-CMs depends both cardiac and non-cardiac myosin ﬁbers, which
prevent deformation of the cell body.
© 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Application of cardiomyocytes derived from human induced
pluripotent stem cells (hiPSC-CMs) for in vivo repair and regener-
ative medicine has been examined (see review articles [1,2] and
references therein). The physiological function of cardiomyocytes is
to output contractile force to the extracellular matrix (ECM), where
the force is sufﬁcient to pump blood throughout the body. Schwan
et al. stated that the contractile force of myocardial mimics
composed of hiPSC-CMs was 10-fold lower than that of the adult
humanmyocardium [3]. Moreover, Lu et al. repopulated hiPSC-CMsived from human induced
P, green ﬂuorescent protein;
utani).
se Society for Regenerative
ative Medicine. Production and hoto a decellularized mouse heart, observed its beating, but found
that the heart tissues was insufﬁcient for pumping blood [4]. Thus,
it is important to produce hiPSC-CMs with greater contractility.
Recently, the group of Dr. Yamashita developed an efﬁcient method
for purifying hiPSC-CMs from human induced pluripotent cell de-
rivatives [5] and demonstrated its application in infarcted hearts
[6]. To expand the applications of hiPSC-CMs, contractile force and
strain energy output should be examined.
Some methods for measuring the contractile force of single
cardiomyocytes have been developed, including polyacrylamide
hydrogel substrates with embedded beads [7,8], poly-
dimethylsiloxane micro pillars [9], and carbon ﬁber tip [10].
Although hydrogel with embedded beads is advantageous for
avoiding the effect of the constrained cellular adhesion area to the
substrate, it is unclear whether the embedded microbeads reﬂect
the gel surface. Thus, visualization of the polymer network itself
should be conducted. Recently, covalently bonded collagen to a
ﬂuorescent dye and observed the cellular response to the collagen
[11]. Since the elastic modulus of the gelled collagen was constantsting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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scale of cell migration [12], ﬂuorescent collagen gel is useful for
measuring cellular contractile force.
The mechanical properties of cells are closely related to the
function of myosin II. Beating contractility of cardiomyocyte de-
pends on the cardiac isoform of myosin II [2]. Based on Hooke's law,
force generated by cardiac myosin II activity balances the sum of
the restoring force to the deformation of the ECM and the cell itself.
Assuming that cardiac myosin II activity is constant, if the cell has
higher elasticity, contractile force output to the ECM will be lower.
In contrast, if the cell has lower elasticity, the contractile force
output will be higher. In non-cardiac cells, cellular elasticity is
highly dependent on the non-cardiac isoform of myosin II [13,14].
Taking previous studies into consideration, we hypothesized that
the contractile force and strain energy output of hiPSC-CMs
depend not only on cardiac myosin II but also on non-cardiac
myosin II.
In this study, we measured the contractile force and strain en-
ergy output of the puriﬁed single hiPSC-CMs. The difference in the
strain energy output between beating hiPSC-CMs was evaluated in
terms of expression of non-cardiac myosin II. The expression of
non-cardiac myosin II in hiPSC-CMs is also discussed.
2. Materials and methods
2.1. Cells culture and plasmid construction
Puriﬁed hiPSC-CMs (Cellartis Cardiomyocytes; catalogue
#Y10071; source #P11012) were purchased from Takara Inc. (Shiga,
Japan). Procedure of the cell culture was conducted following the
manufacturer's instructions. Two weeks after cultivation, hiPSC-
CMs were trypsinized and used in subsequent experiments. The
human ﬁbroblast cell line (MRC-5 SV1 TG1) was purchased from
RIKEN Cell Bank (Tsukuba, Japan) and the culture protocols were
used according to those described previously [15]. Transfection of a
plasmid into hiPSC-CMs and MRC-5 SV1 TG1was performed using
Lipofectamine 2000 (Thermo Fisher Scientiﬁc, Waltham, MA, USA).
To construct the green ﬂuorescent protein (GFP)-tagged cardiac
isoform of myosin regulatory light chain (MRLC), cDNA encoding
full-length MYL2 (accession number: BC031006) was ampliﬁed by
PCR, using the cDNA pool of the hiPSC-CMs, and inserted into the
XhoI-KpnI sites of pAcGFP-N3 (Takara). Primers and plasmid DNA
sequences are shown in Supplementary data. GFP-MRLC expressing
cells were observed by confocal laser scanning microscopy using a
63 objective lens (TCS-SP5; Leica Microsystems, Wetzlar, Ger-
many). Beating hiPSC-CMs were observed at 512  512 pixels and 4
frames/s.
2.2. Preparation and mechanical properties of collagen gel
We purchased porcine-derived type I collagen solution (3 mg/
mL; Cellmatrix-IP; Nitta Gelatin Inc., Osaka, Japan). The collagen
was labeled with Alexa Fluor 546 according to the manufacturer's
instructions (Alexa Fluor protein labeling kit; Thermo Fisher Sci-
entiﬁc). A related method has been reported previously [16]. Ac-
cording to previous reports, collagen gel can be considered an
elastic material under a small strain range (approximately around
0.2, depending on the experimental system) and the strain range
can be widened with increasing collagen concentration [17,18]. To
concentrate the collagen solution, the ﬂuorescent-labeled collagen
solution was centrifuged (Centrisart I; 20,000 MW cut off; Satorius
AG, Goettingen, Germany). Collagen gelation was performed in a
glass-bottom dish (8-well Nunc™ Lab-Tek™ II Chamber Slide™
System; Thermo Fisher Scientiﬁc) according to the Nitta Gelatin
instructions and the ﬁnal concentration of the collagen gel was6 mg/mL. The thickness of the collagen gel was approximately
200 mm.
Prior to contractile force measurement of the gel, we evaluated
Poisson's ratio and elasticity (Young's modulus) of the collagen gel.
We used non-labeled collagen gel (ﬁnal concentration was 6 mg/
mL) in the following Poisson's ratio and the elasticity measure-
ments assuming that the mechanical properties of the ﬂuorescent-
tagged collagen gel and non-labeled collagen gel were the same.
For Poisson's ratio measurement, we prepared a columnar
collagen gel (diameter ¼ 16 mm, height ¼ 3 mm). The gel was
transferred onto a transparent and ﬂat-bottom vat supplied with
HEPES buffered low-glucose Dulbecco's modiﬁed Eagle's medium
(Sigma, St. Louis, MO, USA). We measured changes in the diameter
and the height of the gel using a reading microscope with
increasing load to the gel. Changes in the diameter and height were
converted to longitudinal and lateral strains. Poisson's ratio was
analyzed by dividing lateral strain by longitudinal strain. The
averaged Poisson's ratio was 0.36 (standard deviation was 0.17,
calculated from seven observations).
Measurement of collagen gel elasticity using atomic force mi-
croscopy has been previously described [19]. Brieﬂy, a spherical
bead 100 mm in diameter was indented into the collagen gel, and
the force acting on the bead was recorded as a function of inden-
tation distance. The relationship between force and distance was
analyzed using the Hertzian contact theory. Averaged elasticity was
3.0 kPa (standard deviation was 0.8 kPa based on at least 1000
points).
2.3. Contractile force and strain energy analysis
Time lapse images of the ﬂuorescent-labeled collagen gel sur-
face with beating hiPSC-CMs was observed using a ﬂuorescent
microscope with a 20 objective lens (Ti-E and CFI-Plan Apo
lseries; NIKON, Tokyo, Japan) and sCMOS camera (Zyla 4.2; Andor
Technology Ltd., UK) at 1500  1500 pixels and 10 frames/s. An
example of collagen deformation is shown in Supplemental movie
1. Contractile force (traction force) of hiPSC-CMs was analyzed by
particle image velocimetry and Fourier transform traction cytom-
etry method using ImageJ software plugins [20] (National Institutes
of Health, Bethesda, MD, USA). Brieﬂy, the displacement ﬁeld of the
collagen gel surface between the force-free image and another
image was estimated by particle image velocimetry. The traction
force ﬁeld was obtained by deconvolution of Green's function and
the displacement ﬁeld from Fourier space. The regularization
parameter was set at 1  108 for traction force reconstructions.
Total strain energy U of the collagen gel by the hiPSC-CMs beating
was evaluated using the following equation [21]:
U ¼ 1
2
Z
Tðx; yÞ$uðx; yÞdxdy
where T denotes the traction force vector and u denotes the
displacement vector in a laboratory frame (x, y). Analyzed
displacement, traction force and local strain energy were visualized
using MATLAB software. Representative total strain energy for each
cell was determined as the average of the ﬁve peak values (denoted
as “Max” in the Fig. 1(C)).
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.reth.2016.02.009.
2.4. Immunoﬂuorescent microscopy
The hiPSC-CMs were ﬁxed with 4% formaldehyde/PBS and per-
meabilized with 0.5% Triton X-100/PBS. The cells were stained with
speciﬁc primary and Alexa-labeled secondary antibodies (Thermo
Fig. 1. Measurement and analysis of contractile force and strain energy output for a single cardiomyocyte derived from human induced pluripotent stem cells (hiPSC-CMs). Cells
were cultured on a ﬂuorescent-labeled collagen gel substrate and time lapse imaging of the beating cells was performed by ﬂuorescent microscopy. (A) Collagen deformation caused
by cell beating was captured and visualized. The “subtraction” was conducted by subtracting the two collagen images using ImageJ software. Green solid line and red dashed line
indicate the cellular outline of the relaxed and contracted states, respectively. (B) Using two collagen images, we analyzed the displacement, traction force, and strain energy of the
collagen gel surface. “Max” denotes the analysis using the relaxed and contracted collagen images. “Min” denotes the analysis using the two relaxed collagen images. (C) Time
course of the total strain energy from a cell was plotted.
T. Mizutani et al. / Regenerative Therapy 3 (2016) 90e9692Fisher Scientiﬁc), and thenwashedwith PBS. Information regarding
the primary antibodies used in this study is presented
in Supplemental data. For confocal laser microscope imaging, weused the C1 system (NIKON) with a 20, 60, or 100 objective
lens (CFI-Plan Apo lseries; NIKON). For super resolution imaging,
we used Nikon's Structured Illumination Microscope (N-SIM;
T. Mizutani et al. / Regenerative Therapy 3 (2016) 90e96 93NIKON) with a 100 objective lens (Apo TIRF Oil DIC; NIKON).
Image reconstruction from structured-illumination images was
performed using N-SIM software.
3. Results
3.1. Variety of mechanical outputs of hiPSC-CMs
We measured the mechanical features of single hiPSC-CMs.
Prior to applying single hiPSC-CMs in contractile force measure-
ment, we observed the pulsation of hiPSC-CMs (beating cells were
more than 90%) on the collagen-coated glass substrate (represen-
tative movie is shown as Supplemental movie 2). Each cell beat
under the low cell-density condition. The periodicity of the beating
was not uniform, but ranged from 0.2 to 1.0 Hz.
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.reth.2016.02.009.
Next, we measured the contractile force and strain energy of
isolated hiPSC-CMs. The hiPSC-CMs were cultured on ﬂuorescent-
tagged collagen gel and beating was observed (Fig. 1(A)). Displace-
ment of the collagen gel surface, contractile force (traction force),
and strain energy of single hiPSC-CMs were analyzed using a set of
time-lapse images for the beating collagen gel surface (Fig. 1(B)). In
the data set, the most compacted state for 5 beats was denoted as
“Max” and the relaxed state was denoted as “Min”. We conﬁrmed
that the distribution of collagen deformation (Fig. 1(A)) corre-
sponded to the distribution of displacement, traction force, and
strain energy in the most compacted state. To elucidate temporal
changes in the strain energy output, we integrated the strain energy
density for the ﬁeld of the image shown in Fig. 1(B), and the time
dependency of the total strain energy (plane integration of strain
energy density) was plotted as shown in Fig. 1(C). These results
showed that our experimental system and analysis were effective
for evaluating the strain energy output of single hiPSC-CMs.
To observe cellular variations in contractility, we analyzed the
distribution of representative values of total strain energy. First, we
considered the validity of the representative value of total strain
energy. The representative value was determined as the average of
5 peak values. To examine whether the representative value
changed during cellular activity, we measured the total strain en-
ergy of three cells at a 24 h interval and compared their changes
(Fig. 2(A)). Standard deviations for each data point were less than
20% of the average. There was no clear difference in the average
strain energy during the 24 h cell cultivation. This indicates that the
average strain energy of each cell can be considered as aFig. 2. Cell-dependent difference in the strain energy output. (A) Temporal changes in the to
from a single cell were averaged (peak denotes “Max” in Fig. 1(C)). The analysis was perform
cell were very small, although the average strain energy differed between the three cells. E
cultivation mentioned in the Fig. 2(A)) was averaged and plotted in the histogram. Strain erepresentative value. Next, we measured the total strain energy of
single hiPSC-CMs and plotted their representative values on a
histogram (Fig. 2(B)). The total strain energy of each cell was not
uniform, but ranged from 0.2 to 5.8 pJ. These results suggest that
mechanical outputs from single hiPSC-CMs were not uniform, but
differed between cells.
3.2. Heterogeneous ﬁlament networks of myosin II isoforms
To address the molecular mechanism of the varying strain en-
ergy output between cells, we determined the relationship be-
tween stain energy output and the ﬁbrous distribution of MRLC
isoforms, such as cardiac (contributes to beating) and non-cardiac
(does not concern beating) MRLC. Strain energy on the
ﬂuorescent-labeled collagen gel was measured, and then the cells
were ﬁxed and stained with speciﬁc antibodies for the cardiac and
non-cardiac MRLC. The cells showing high strain energy output
(greater than 4 pJ) generally exhibited weak non-cardiac MRLC ﬁ-
bers (Fig. 3(A)). The cells showing low strain energy output (less
than 2 pJ) generally exhibited strong non-cardiac MRLC ﬁbers
(Fig. 3(B)). However, we identiﬁed no speciﬁc features from the
cardiac MRLC signals. These results suggest that strain energy
output related to the degree of the non-cardiac myosin II ﬁbers.
Next, we observed the detailed ﬁlament networks of myosin II
isoforms in hiPSC-CMs by confocal laser microscopy (Fig. 4) or su-
per resolution microscopy (Supplemental data). Localization of
cardiac and non-cardiac MRLC was different, forming heteroge-
neous ﬁlaments rather than a ﬁlament consisting of cardiac and
non-cardiac (arrows and arrowheads in Fig. 4). The ﬁlament
network of cardiac MRLC included some straight and curved areas.
To consider the validity of the curved ﬁber, we observed the
localization of cardiac muscle actin using a speciﬁc antibody
(Supplemental data).We observed forming curved actin ﬁber net-
works such as in cardiac MRLC localization. These results indicate
that cardiac and non-cardicac MRLC constructed heterogeneous
ﬁber networks.
To determine whether cardiac MRLC can be used as a substitute
for non-cardiac MRLC, GFP-tagged cardiac MRLC was expressed
with the human ﬁbroblast cell line (MRC-5) and in hiPSC-CMs
(Fig. 5). In ﬁbroblast cells, GFP signals were diffused in the cyto-
plasm and nucleus. In contrast, GFP signals formed ﬁbers in hiPSC-
CMs. We also observed that hiPSC-CMs expressing the GFP-tagged
cardiac MRLC can beat (Supplemental movie 3). These results
indicate that cardiac and non-cardicac MRLC formed functionally
different ﬁber networks in different locations.tal strain energy of three cells were evaluated. The ﬁve peaks of the total strain energy
ed again after 24 h cultivation. Temporal changes in the averaged strain energy from a
rror bars denote standard deviation. (B) Total strain energy from 92 cells (before 24 h
nergy output was non-uniformly distributed between cells.
Fig. 3. Relationship between strain energy output and myosin II isoform expression. Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) were
cultured on the collagen gel. Traction force and total strain energy of the cells were measured. Next, the cells were ﬁxed and stained with antibodies for the cardiac isoform of
myosin II regulatory light chain (MRLC) and non-cardiac isoform of MRLC. Red lines in the bright ﬁeld image show cellular outlines. Representative data for the high energy cell (A)
and low energy cell (B) are shown.
T. Mizutani et al. / Regenerative Therapy 3 (2016) 90e9694Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.reth.2016.02.009.
4. Discussion
In this study, we showed that the contractile force and strain
energy output of hiPSC-CMs were non-uniformly distributedbetween cells (Fig. 2). Although the collagen gel was not uniform
(Fig. 1(A) and the elasticity distribution measured by AFM), the
distribution of elasticity was not sufﬁcient for the broad distribu-
tion of strain energy output by hiPSC-CMs (Fig. 2(B)). Cells showing
high strain energy output generally contained weak non-cardiac
myosin II ﬁbers and vice versa (Fig. 3). Cardiac myosin II and non-
cardiac myosin II formed heterogeneous ﬁber networks (Fig. 4).
Fig. 4. Myosin II isoforms constructed heterogeneous ﬁlament networks. Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) were cultured on the
glass substrate, ﬁxed and stained with speciﬁc antibodies for the cardiac isoform of myosin II regulatory light chain (MRLC) and non-cardiac isoform of MRLC. Immunoﬂuorescent
images were acquired by confocal laser microscopy with a 20 or 100 objective lens. Representative cells are shown. The arrows and arrowheads indicate the different ﬁber
networks.
Fig. 5. Cardiac isoform of myosin II regulatory light chain (MRLC) could not substitute
for the non-cardiac isoform of MRLC. A plasmid for the GFP-tagged cardiac MRLC was
transfected into cardiomyocytes derived from human induced pluripotent stem cells
(hiPSC-CMs) and the human ﬁbroblast cell line (MRC-5). The localization of GFP signals
was compared.
T. Mizutani et al. / Regenerative Therapy 3 (2016) 90e96 95Regardless of whether the heterogeneous ﬁber networks showed
the same alignment, the beating component (cardiac myosin II ﬁ-
bers) contributed to the generation of the beating force, while the
non-beating component (non-cardiac myosin II ﬁbers) resisted
beating force through its elasticity. Considering this, we conﬁrmed
that non-cardiac myosin II ﬁbers networks functioned as an elastic
material and weakened the contractile force and energy output of
hiPSC-CMs.
The reason why the degree of non-cardiac myosin II ﬁbers for-
mations differed between cells remains unclear. Differences in the
maturation of hiPSC-CMs may affect non-cardiac myosin II ﬁber
formation. The maturation of hiPSC-CMs changes some cardio-
related protein [22] and alters cellular morphologies and func-
tions [23]. As the maturation process slightly differs between cells,
expression in non-cardiac myosin II may be affected. Non-cardiac
MRLC expression in cardiomyocytes is not unusual, because one
type of non-cardiac MRLC (myosin, light chain 12A, NM_006471) is
expressed in the heart at the same level as in the muscle according
to the GeneChip database (http://refex.dbcls.jp/index.php).
Expression may be regulated in the unique manner exhibited by
induced pluripotent stem cells.
To obtain high contractile-force hiPSC-CMs, in addition to the
cell sorting using speciﬁc protein markers, genomic manipulation
or cell sorting based on cellular mechanical properties is required.
To differentially regulate cardiac and non-cardiac myosin II, a car-
diac myosin II-speciﬁc regulator [24] is one target of genomicmanipulation. Cell sorting depending on mechanical properties
such as cellular stiffness [25] should also be examined.
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